Niels Svenstrup
Corporate Officer/Principal presso PEPGEN INC.
Patrimonio netto: - $ in data 31/05/2024
Provenienza dei contatti di primo grado di Niels Svenstrup
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 27 | |
16
| Public Company | Biotechnology | 16 |
| Public Company | Pharmaceuticals: Major | 9 | |
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA.
1
| Extinct | Pharmaceuticals: Generic | 1 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Niels Svenstrup tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Copenhagen | College/University | Graduate Degree Undergraduate Degree Director/Board Member Doctorate Degree Doctorate Degree | |
Lundbeck Foundation
 Lundbeck Foundation Investment Trusts/Mutual FundsMiscellaneous Lundbeck Foundation maintains and expands the activities of the Lundbeck Group. It provides funding for scientific research. Its support of scientific activities takes place mainly through the financing of concrete scientific projects in the areas of biomedicine and natural sciences. The firm grants a number of stipends and fellowships, and also supports education and procurement activities in biomedical and natural sciences. The company was founded by Grete Lundbeck on March 4, 1954 and is headquartered in Copenhagen, Denmark. | Investment Trusts/Mutual Funds | Chief Executive Officer Director/Board Member Corporate Officer/Principal Director/Board Member Chief Executive Officer | |
| TDC A/S | Major Telecommunications | Chairman Director of Finance/CFO Director/Board Member Director/Board Member | |
| ALK-ABELLÓ A/S | Biotechnology | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| COLOPLAST A/S | Medical Specialties | Director/Board Member Director of Finance/CFO Chairman | |
| Copenhagen Business School | College/University | Graduate Degree Masters Business Admin Undergraduate Degree | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Chairman Chief Tech/Sci/R&D Officer | |
Falck A/S
 Falck A/S Services to the Health IndustryHealth Services Falck A/S offers emergency assistance, rescue, healthcare, and training services. It provides emergency medical services to people through their ambulances, fire-fighting, fire training, and consultancy services to industrial customers; assistance in airports within the areas of fire services and personal assistance to travelers; and fire services and emergency services in airports. The firm also facilitates roadside assistance in case of an accident or breakdown of cars, trucks, busses, caravans, trailers, bicycles, motorcycles, and boats; travel assistance services to leisure travelers, business travelers, and expatriates; and fleet management services, as well as installs and services alarms in private homes and places of businesses. It also owns shares or other securities of domestic and foreign companies. The company was founded on August 23, 2004 and is headquartered in Copenhagen, Denmark. | Services to the Health Industry | Chairman Chairman Director/Board Member | |
| AEROVATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member Chairman | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
Lundbeck Pharma A/S
 Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Medical Distributors | Chief Executive Officer Chief Operating Officer Director/Board Member | |
Imbria Pharmaceuticals, Inc.
 Imbria Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Imbria Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company developing novel therapies that restore cellular energy deficits. It focuses on restoring or improving the cell?s ability to produce energy where energy imbalances are at the root of disease, including cardiovascular diseases and inborn errors of metabolism. The company was founded by Andrew Levin and David-Alexandre C. Gros in 2018 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Lundbeck Ltd.
 Lundbeck Ltd. Pharmaceuticals: MajorHealth Technology Lundbeck Ltd. engages in the research, development, production, marketing and sale of pharmaceuticals. It provides services that aid in the treatment of CNS disorders, including depression, schizophrenia, Alzheimer's disease, Parkinson's disease, Huntington's disease, epilepsy and insomnia. The company was founded in 1972 and is headquartered in St. Albans, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| Harvard Business School | College/University | Graduate Degree Masters Business Admin | |
LEGO A/S
 LEGO A/S Recreational ProductsConsumer Durables LEGO A/S manufactures and markets play materials and toys. The firm offers preschool products, such as loose bricks, play themes, and educational toys for kindergarten toddlers, schoolchildren and teenagers. The company was founded by Ole Kirk Kristiansen in 1932 and is headquartered in Billund, Denmark. | Recreational Products | Director/Board Member Director of Finance/CFO | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | President Director of Finance/CFO | |
| DBV TECHNOLOGIES | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ASCENDANT RESOURCES INC. | Other Metals/Minerals | Chief Executive Officer Chief Operating Officer | |
Syncona Partners LLP
 Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| University of Aalborg | College/University | Graduate Degree Undergraduate Degree | |
| ALNYLAM PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
International N&H Denmark ApS
 International N&H Denmark ApS Food: Major DiversifiedConsumer Non-Durables DuPont Nutrition Biosciences ApS is engaged in the production of food enzymes, products and pharmaceutical grade excipients for food products. It operates through the following divisions: Enablers, BioActives, Sweeteners, Cultures, Genecor and Sales and Application Food Ingredients. The Enablers division develops, produces and markets emulsifiers, hydrocolloids, and tailored systems that enable food & beverage manufactureres to make appealing products. The BioActives division is comprised of the Cultures and Sweeteners divisions. It offers food cultures and protective solutions, speciality sweeteners, health ingredients, and microorganisms for agriculture and animal nutrition. The Genencor division develops innovative enzymes and bioproducts to reduce the environmental impact of the cleaning, textile, fuel, and chemical industries. The sales and Application food Ingredients division manages and budgets global key accounts. The company was founded in 1989 and is headquartered Copenhagen, Denmark | Food: Major Diversified | Director/Board Member Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Lundbeckfond Invest A/S
 Lundbeckfond Invest A/S Investment ManagersFinance Lundbeckfond Invest A/S (Lundbeckfond Invest) is the investment management subsidiary of the Lundbeck Foundation in Denmark. Established in 1999, the firm is based in Copenhagen and manages the Lundbeck Foundation's investments, aiming for long-term, stable returns with moderate risk, such that the Foundation's net capital is not jeopardized and the Foundation is able to meet its commitments in terms of awarding grants and of laying a capital base for its subsidiaries. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| CHEMOMETEC A/S | Medical Specialties | Chairman Director/Board Member | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| University of Pennsylvania | College/University | Undergraduate Degree Undergraduate Degree | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| GILEAD SCIENCES, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| GN STORE NORD A/S | Telecommunications Equipment | Chairman Corporate Officer/Principal | |
Pepgen Ltd.
 Pepgen Ltd. Packaged SoftwareTechnology Services Pepgen Ltd. engages in research and experimental development on biotechnology. The company was founded on January 25, 2018 and is headquartered in Oxford, the United Kingdom. | Packaged Software | Chief Executive Officer Corporate Officer/Principal | |
The Friedreich's Ataxia Research Alliance
 The Friedreich's Ataxia Research Alliance Information Technology ServicesTechnology Services The Friedreich's Ataxia Research Alliance provides patient registry services. The private company is based in Downingtown, PA. | Information Technology Services | Director/Board Member Corporate Officer/Principal | |
| GSK PLC | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
X-Vax Technology, Inc.
 X-Vax Technology, Inc. BiotechnologyHealth Technology X-Vax Technology, Inc. operates as a biotechnology company. The company was founded in 2015 and is headquartered in New York, NY. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
H. Lundbeck AS (Norway)
 H. Lundbeck AS (Norway) Pharmaceuticals: MajorHealth Technology H. Lundbeck AS trades pharmaceutical and healthcare products. It provides drugs for the treatment of depression, schizophrenia, alzheimers, and Parkinsons diseases. The company was founded in 1948 and is headquartered in Lysaker, Norway. | Pharmaceuticals: Major | Chief Operating Officer Chairman | |
Danish-American Business Forum
 Danish-American Business Forum Miscellaneous Commercial ServicesCommercial Services The Danish-American Business Forum operates as a business organization. | Miscellaneous Commercial Services | Chairman Director/Board Member | |
| VELOXIS PHARMACEUTICALS A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chairman | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
| University of Oxford | College/University | Doctorate Degree Doctorate Degree | |
NightstaRx Ltd.
 NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Medical/Nursing Services | Chief Executive Officer Director/Board Member | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Vtesse, Inc.
 Vtesse, Inc. BiotechnologyHealth Technology Vtesse, Inc. provides novel drugs for life-threatening rare diseases. It developed VTS-270, a modified form of cyclodextrin that has been evaluated in preclinical and clinical studies at institutes within the National Institutes of Health (NIH) to treat patients with Niemann-Pick Disease Type C (NPC). The firm is working with the NIH and other leading academic centers to advance clinical study of VTS-270 for NPC, and to conduct pre-clinical discovery and development of other novel drugs for NPC and other LSDs. The company was founded by Ben Machielse in 2015 and is headquartered in Gaithersburg, MD. | Biotechnology | Director/Board Member Founder | |
| HANSA BIOPHARMA AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Cydan LLC
 Cydan LLC Medical DistributorsDistribution Services Cydan LLC operates as an orphan drug accelerator that identifies and de-risks programs. The firm's model evaluates programs for treating rare diseases with unmet medical need and is aimed at creating new companies to develop those therapies. The company was founded by James G. McArthur in 2013 and is headquartered in Cambridge, MA. | Medical Distributors | Director/Board Member Founder |
Statistiche
Distribuzione geografica
| Danimarca | 20 |
| Stati Uniti | 19 |
| Regno Unito | 7 |
| Svezia | 4 |
| Francia | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 7 |
| Commercial Services | 6 |
| Health Services | 3 |
| Distribution Services | 3 |
Posizioni
| Director/Board Member | 324 |
| Chairman | 125 |
| Corporate Officer/Principal | 111 |
| Independent Dir/Board Member | 105 |
| Chief Executive Officer | 68 |
Contatti più connessi
- Borsa valori
- Insiders
- Niels Svenstrup
- Connessioni Società
